Delta-type opioid receptor
G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
| Database | Links |
|---|---|
| UniProt | P32300 |
| PDB | 4EJ4 |
| BioGrid | Not available |
| BindingDB | P32300 |
| DrugBank | Not available |
| Guide to PHARMACOLOGY | 317 |
| PharmGKB | Not available |
| KEGG | mmu:18386 |
| BioCyc | Not available |
| Entrez Gene (GeneID) | 18386 |
| Metric | Mean Value | Standard Deviation |
|---|---|---|
| AUC | 0.9575 | 0.0019 |
| Accuracy | 0.9112 | 0.0035 |
| Sensitivity | 0.9332 | 0.0058 |
| Specificity | 0.8845 | 0.0062 |
| BEDROC | 0.9758 | 0.006 |
| MCC Threshold | 0.4 | N/A |
| MCC | 0.8376 | N/A |
| F-score Threshold | 0.4 | N/A |
| F-score | 0.9287 | N/A |